Gilead-Vertex Deal Has 'Low Probability' Of Happening, RBC Capital Says By: Benzinga via Benzinga April 21, 2015 at 12:57 PM EDT In a report published Tuesday, RBC Capital Markets analyst Michael Yee commented on the increasing Street "appreciation" ... Read More >> Related Stocks: Gilead Sciences Vertex Pharmaceuticals